Century Therapeutics
Develops iPSC-derived allogeneic cell therapies for autoimmune disease and cancer.
$2.03
After-hours close+0.00 (+0.25%)
At close$2.03(−9.19%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 160.28%Insiders 7.12%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 86.57M · Float 48.65M · 56.2% free float
Institutions13F, as of Mar 31, 2026
74 holders · 138.75M shares · 33 new positions · 48 increased · 13 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 17.75M | 20.51% | +17.75Mnew | May 15, 2026 |
| TCG Crossover Management, LLC | 17.75M | 20.51% | +17.75Mnew | May 15, 2026 |
| Versant Venture Management, LLC | 12.17M | 14.05% | +12.17Mnew | May 5, 2026 |
| Deep Track Capital, LP | 9.49M | 10.96% | +9.49Mnew | May 15, 2026 |
| Commodore Capital LP | 8.70M | 10.04% | +8.70Mnew | May 15, 2026 |
| VR Adviser, LLC | 8.70M | 10.04% | +8.70Mnew | May 15, 2026 |
| RTW Investments, LP | 8.70M | 10.04% | +8.70Mnew | May 15, 2026 |
| Point72 Asset Management, L.P. | 5.96M | 6.89% | +3.0K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| RA Capital Management, L.P. | 9.90% | 17.94M | 13G | Jan 16, 2026 ↗ |
| Deep Track Capital, LP | 7.34% | 13.49M | 13G | Jan 15, 2026 ↗ |
| RTW Investments, LP | 7.10% | 13.04M | 13G | May 15, 2026 ↗ |
| Commodore Capital LP | 7.10% | 13.04M | 13G | Jan 16, 2026 ↗ |
| Venrock Healthcare Capital Partners III, L.P. | 7.10% | 13.04M | 13G | Jan 16, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Brent Pfeiffenberger | director, officer: President and CEO | 3.63M | 4.20% | Aug 18, 2026 |
| Chad Cowan | officer: Chief Scientific Officer | 1.19M | 1.37% | Jun 15, 2026 |
| Gregory Russotti | officer: See Remarks | 512.3K | 0.59% | Jun 15, 2026 |
| Douglas Carr | officer: SVP Finance & Operations | 504.8K | 0.58% | Aug 5, 2026 |
| Adrienne Farid | officer: Chief Operations Officer | 250.1K | 0.29% | Jun 11, 2025 |
| Morgan Conn | officer: Chief Finanical Officer | 79.6K | 0.09% | Mar 12, 2025 |
3 ten-percent owners hold 28.80M shares by Form 4, outside the officers-and-directors figure above · 9 people have not refiled in the last 18 months (15.44M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 3, 2026 | Douglas Carrofficer: SVP Finance & Operations | Sale | 275 | $1.98 | 504,819 |
| Jun 12, 2026 | Douglas Carrofficer: SVP Finance & Operations | Sale | 1,654 | $2.23 | 505,094 |
| Jun 12, 2026 | Gregory Russottiofficer: See Remarks | Sale | 2,584 | $2.23 | 512,319 |
| Jun 8, 2026 | Douglas Carrofficer: SVP Finance & Operations | Sale | 249 | $2.11 | 506,748 |
| Jun 8, 2026 | Gregory Russottiofficer: See Remarks | Sale | 524 | $2.11 | 514,903 |
| May 4, 2026 | Douglas Carrofficer: SVP Finance & Operations | Sale | 264 | $2.34 | 506,997 |
| Mar 12, 2026 | Gregory Russottiofficer: See Remarks | Sale | 10,076 | $2.55 | 515,427 |
| Mar 12, 2026 | Douglas Carrofficer: SVP Finance & Operations | Sale | 7,043 | $2.55 | 507,261 |
| Mar 9, 2026 | Gregory Russottiofficer: See Remarks | Sale | 479 | $2.54 | 525,503 |
| Mar 9, 2026 | Douglas Carrofficer: SVP Finance & Operations | Sale | 247 | $2.54 | 514,304 |
CongressHouse and Senate disclosures
Not reported.